|
1
|
Conjugated linoleic acid modulates immune responses in patients with mild to moderately active Crohn's disease.
|
Clin Nutr
|
2012
|
2.11
|
|
2
|
Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial.
|
Gastroenterology
|
2003
|
1.70
|
|
3
|
MicroRNAs Classify Different Disease Behavior Phenotypes of Crohn's Disease and May Have Prognostic Utility.
|
Inflamm Bowel Dis
|
2015
|
1.00
|
|
4
|
A randomized, controlled, double-blind trial of air insufflation versus carbon dioxide insufflation during ERCP.
|
Gastrointest Endosc
|
2010
|
0.94
|
|
5
|
Preemptive pharmacogenetic testing: insufficient data equal unsatisfactory guidance.
|
Ann Intern Med
|
2011
|
0.93
|
|
6
|
Contribution of higher risk genes and European admixture to Crohn's disease in African Americans.
|
Inflamm Bowel Dis
|
2012
|
0.88
|
|
7
|
A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis.
|
Gastroenterology
|
2006
|
0.83
|
|
8
|
Efficacy of methotrexate in ulcerative colitis: failure or promise.
|
Inflamm Bowel Dis
|
2010
|
0.83
|
|
9
|
Use of Biologics in Pouchitis: A Systematic Review.
|
J Clin Gastroenterol
|
2015
|
0.83
|
|
10
|
NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans.
|
Am J Gastroenterol
|
2009
|
0.80
|
|
11
|
Ethical issues, safety, and data integrity in clinical trials.
|
Inflamm Bowel Dis
|
2005
|
0.80
|
|
12
|
Ciprofloxacin for the prevention of postoperative recurrence in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study.
|
Inflamm Bowel Dis
|
2013
|
0.80
|
|
13
|
Design issues and outcomes in IBD clinical trials.
|
Inflamm Bowel Dis
|
2005
|
0.79
|
|
14
|
Migraine in patients with inflammatory bowel disorders.
|
J Clin Gastroenterol
|
2009
|
0.79
|
|
15
|
Methotrexate: underused and ignored?
|
Dig Dis
|
2013
|
0.77
|
|
16
|
Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases.
|
Inflamm Bowel Dis
|
2016
|
0.76
|
|
17
|
Response to letter to the editor - implementation of integrative approaches to improve the design of Crohn's disease clinical trials.
|
Clin Nutr
|
2012
|
0.75
|
|
18
|
Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers.
|
Inflamm Bowel Dis
|
2016
|
0.75
|
|
19
|
IBD LIVE Series-Case 8: Treatment Options for Refractory Esophageal Crohn's Disease and Hidradenitis Suppurativa.
|
Inflamm Bowel Dis
|
2017
|
0.75
|